California mandates comprehensive compliance programs for pharmaceutical companies

Drug Benefit Trends

Volumn 17, Issue 6, 2005, Pages 242-243

  Ung, Diane ^a  

^a FOLEY AND LARDNER LLP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG INDUSTRY; DRUG MARKETING; PHARMACY; PHYSICIAN; PRACTICE GUIDELINE; SHORT SURVEY; UNITED STATES;

EID: 23944435002     PISSN: 10805826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (9)

1. 2004 Cal Stat ch 927, codified at Cal Health & Safety §119400.
2. 68 Federal Register 23731 (May 5, 2003). Available at: http://oig.hhs.gov/ authorities/docs/03/050503FRCPGPharmac.pdf. Accessed May 24, 2005.
3. Pharmaceutical Research and Manufacturers of America. PhRMA Code on Interactions With Healthcare Professionals. Available at: www.phrma.org/ publications/policy/ /2004-01-19.391.pdf. Accessed May 24, 2005.
4. Vt Stat tit 33, §2005.
5. Vt Stat tit 33, §2005a.
6. Me Rev Stat tit 22, §2698-A.
7. WVa Code §5A-3C-13.
8. DC Stat §48-833.
9. Minn Stat §151.461 (2004).